产品详情
In vitro | DMSO | 90 mg/mL (173.18 mM) | |
Water | Insoluble | ||
Ethanol | 90 mg/mL (173.18 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.24 mL | 96.21 mL | 192.42 mL |
0.5 mM | 3.85 mL | 19.24 mL | 38.48 mL |
1 mM | 1.92 mL | 9.62 mL | 19.24 mL |
5 mM | 0.38 mL | 1.92 mL | 3.85 mL |
*The above data is based on the productmolecular weight 519.7 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11332 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 519.7 |
Formula | C27H45N5O5 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 394730-60-0 |
Synonyms | EBP 520, SCH 503034 |
SMILES | CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C |
产品资料
产品标签
Product Questions
Product Questions
Gefitinib (Iressa)
Gefitinib (Iressa)是一种EGFR抑制剂,可阻断靶细胞中表皮生长因子受体(EGFR)的信号传导。
Mubritinib (TAK 165)
Mubritinib (TAK 165)是一种有效的EGFR和p34cdc2抑制剂,IC50分别为6 nM和0.2 ?M。Mubritinib(TAK 165)也抑制p33cdk2和p33cd…
ASP8273 (Naquotinib)
ASP8273 (Naquotinib)是不可逆的,第三代,选择性突变的表皮生长因子受体(EGFR)抑制剂,具有潜在的抗肿瘤…
BMS-790052 (Daclatasvir)
BMS-790052 (Daclatasvir)是一种高度选择性的HCV NS5A抑制剂,EC50为9-50 pM,用于治疗丙型肝炎病毒(HCV)感染。
XL647 (Tesevatinib)
XL647 (Tesevatinib)是一种口服生物可利用的小分子RTK抑制剂,可结合并抑制在肿瘤细胞增殖和肿瘤血管形成中…